{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:47:06Z","timestamp":1768434426278,"version":"3.49.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T00:00:00Z","timestamp":1483056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0163619","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T15:15:33Z","timestamp":1483974933000},"page":"e0163619","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Electrocardiographic Biomarkers for Detection of Drug-Induced Late Sodium Current Block"],"prefix":"10.1371","volume":"11","author":[{"given":"Jose","family":"Vicente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Johannesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meisam","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay W.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip T.","family":"Sager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Pueyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,12,30]]},"reference":[{"key":"ref1","unstructured":"ICH. ICH Topic S7B The nonclinical Evaluation of the Potential for delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals. 2005."},{"key":"ref2","unstructured":"ICH. Guidance for Industry E14 Clinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs 2005 [11\/10\/2015]. 61134]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm073153.pdf\" xlink:type=\"simple\">http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm073153.pdf<\/ext-link>."},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40264-013-0016-z","article-title":"Dealing with global safety issues: was the response to QT-liability of non-cardiac drugs well coordinated?","volume":"36","author":"N Stockbridge","year":"2013","journal-title":"Drug Saf"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.0000139333.83620.5D","article-title":"Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties","volume":"110","author":"C Antzelevitch","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/cvr\/cvm069","article-title":"Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone","volume":"77","author":"L Wu","year":"2008","journal-title":"Cardiovascular research"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development","volume":"58","author":"WS Redfern","year":"2003","journal-title":"Cardiovascular research"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.RES.64.5.977","article-title":"Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current","volume":"64","author":"CT January","year":"1989","journal-title":"Circulation research"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1540-8167.2006.00698.x","article-title":"L-type calcium current reactivation contributes to arrhythmogenesis associated with action potential triangulation","volume":"18","author":"D Guo","year":"2007","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ahj.2013.11.004","article-title":"Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium","volume":"167","author":"PT Sager","year":"2014","journal-title":"Am Heart J"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/clpt.2014.155","article-title":"Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil","volume":"96","author":"L Johannesen","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"ref11","article-title":"Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial","author":"L Johannesen","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001615","article-title":"Comprehensive T wave Morphology Assessment in a Randomized Clinical Study of Dofetilide, Quinidine, Ranolazine, and Verapamil","volume":"4","author":"J Vicente","year":"2015","journal-title":"Journal of the American Heart Association"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Couderc J, Vaglio M, Xia X, McNitt S, Hyrien O, editors. Electrocardiographic method for identifying drug-induced repolarization abnormalities associated with a reduction of the rapidly activating delayed rectifier potassium current. Engineering in Medicine and Biology Society, 2006 EMBS&apos;06 28th Annual International Conference of the IEEE; 2006: IEEE.","DOI":"10.1109\/IEMBS.2006.4398329"},{"key":"ref14","unstructured":"Johannesen L, Vicente J, Galeotti L, Strauss DG, editors. Ecglib: Library for processing electrocardiograms. Comput Cardiol; 2013: IEEE."},{"key":"ref15","article-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"J Cohen","year":"1992","journal-title":"Psychol Bull"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","author":"ER DeLong","year":"1988","journal-title":"Biometrics"},{"key":"ref18","first-page":"302","article-title":"C4.5: programs for machine learning","author":"JR Quinlan","year":"1993"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1145\/1656274.1656278","article-title":"The WEKA data mining software: an update","volume":"11","author":"M Hall","year":"2009","journal-title":"ACM SIGKDD explorations newsletter"},{"key":"ref20","unstructured":"Drugs@FDA. Moxifloxacin label 2015 [cited 2015 11\/10\/2015]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/205572s000lbl.pdf\" xlink:type=\"simple\">http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/205572s000lbl.pdf<\/ext-link>."},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1067\/mcp.2000.111482","article-title":"Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects","volume":"68","author":"JL Demolis","year":"2000","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1177\/0091270010381498","article-title":"Population Pharmacokinetic and Concentration\u2014QTc Models for Moxifloxacin: Pooled Analysis of 20 Thorough QT Studies","volume":"51","author":"JA Florian","year":"2011","journal-title":"J Clin Pharmacol"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0828-282X(07)70850-4","article-title":"Torsade de pointes associated with moxifloxacin: A rare but potentially fatal adverse event","volume":"23","author":"T Altin","year":"2007","journal-title":"Can J Cardiol"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1345\/aph.1H474","article-title":"Moxifloxacin and torsade de pointes","volume":"41","author":"KM Dale","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"1","key":"ref25","first-page":"71","article-title":"Moxifloxacin-induced torsades de pointes","volume":"15","author":"S Sherazi","year":"2008","journal-title":"Cardiol J"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/MAJ.0b013e3181a3c2c9","article-title":"Moxifloxacin-induced QT prolongation and torsades: an uncommon effect of a common drug","volume":"338","author":"A Badshah","year":"2009","journal-title":"Am J Med Sci"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2796.2005.01589.x","article-title":"Long QT syndrome: reduced repolarization reserve and the genetic link","volume":"259","author":"D Roden","year":"2006","journal-title":"J Intern Med"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"DM Roden","year":"2004","journal-title":"N Engl J Med"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1540-8167.2006.00698.x","article-title":"L-Type Calcium Current Reactivation Contributes to Arrhythmogenesis Associated with Action Potential Triangulation","volume":"18","author":"D Guo","year":"2007","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"95","key":"ref30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/clpt.2013.238","article-title":"Improving the Assessment of Heart Toxicity for All New Drugs Through Translational Regulatory Science","author":"L Johannesen","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"ref31","unstructured":"ICH E14 Implementation Working Group. ICH E14 Guideline: The Clinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs Questions &amp; Answers (R3) 2015 [2\/6\/2016]. 61134]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E14\/E14_Q_As_R3__Step4.pdf\" xlink:type=\"simple\">http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E14\/E14_Q_As_R3__Step4.pdf<\/ext-link>."},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s40264-015-0325-5","article-title":"Implications of the IQ-CSRC Prospective Study: Time to Revise ICH E14","volume":"38","author":"B Darpo","year":"2015","journal-title":"Drug Saf"},{"key":"ref33","article-title":"The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative\u2014Update on progress","author":"T Colatsky","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"12","key":"ref34","doi-asserted-by":"crossref","first-page":"e0166925","DOI":"10.1371\/journal.pone.0166925","article-title":"Automated Algorithm for J-Tpeak and Tpeak-Tend Assessment of Drug-Induced Proarrhythmia Risk","volume":"11","author":"L Johannesen","year":"2016","journal-title":"PLoS ONE"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0197952","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0163619","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T05:28:18Z","timestamp":1568698098000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0163619"}},"subtitle":[],"editor":[{"given":"Randall Lee","family":"Rasmusson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,30]]},"references-count":34,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0163619","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0197952","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,30]]}}}